FCP
HCA icon

Fidelis Capital Partners’s HCA Healthcare HCA Stock Holding History

Fidelis Capital Partners’s Portfolio HCA Stock Details HCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.03M Sell
2,171
-10
-0.5% -$5.03K 0.07% 206
2025
Q4 		$1.02M Sell
2,181
-13
-0.6% -$6.04K 0.07% 199
2025
Q3 		$935K Buy
2,194
+11
+0.5% +$4.26K 0.07% 204
2025
Q2 		$799K Buy
2,183
+10
+0.5% +$3.6K 0.07% 201
2025
Q1 		$713K Buy
2,173
+16
+0.7% +$5.15K 0.08% 199
2024
Q4 		$721K Sell
2,157
-12
-0.6% -$4.19K 0.07% 202
2024
Q3 		$889K Sell
2,169
-1
-0% -$366 0.11% 164
2024
Q2 		$764K Buy
2,170
+99
+5% +$32.2K 0.11% 160
2024
Q1 		$691K Sell
2,071
-315
-13% -$96.3K 0.1% 176
2023
Q4 		$646K Buy
2,386
+383
+19% +$94.7K 0.14% 146
2023
Q3 		$493K Buy
2,003
+299
+18% +$81.8K 0.17% 132
2023
Q2 		$517K Buy
1,704
+137
+9% +$38.1K 0.19% 129
2023
Q1 		$436K Buy
1,567
+531
+51% +$135K 0.19% 131
2022
Q4 		$259K Buy
+1,036
New +$232K 0.31% 93

Other funds holding HCA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fidelis Capital Partners's HCA Position: Q1 2026 in Review

Fidelis Capital Partners reduced its HCA Healthcare (HCA) stake by 0.46% in Q1 2026, selling an estimated $5.03K and leaving 2,171 shares worth $1.03M. The position accounts for 0.07% of the portfolio, ranked #206.

Fidelis Capital Partners first reported a position in HCA in Q4 2022 and has held it in 14 quarters since. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Fidelis Capital Partners held 2,171 shares of HCA Healthcare worth $1.03M as of Q1 2026.
  • Fidelis Capital Partners sold 10 HCA Healthcare shares in Q1 2026, an estimated $5.03K.
  • HCA Healthcare made up 0.07% of Fidelis Capital Partners's portfolio in Q1 2026, its #206 holding.
  • Fidelis Capital Partners first reported a position in HCA Healthcare in Q4 2022 and has held it in 14 quarters since.
  • 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Fidelis Capital Partners's 13F filing for Q1 2026, filed 6 May 2026.